GABA A Receptor beta 2 + 3 Antibody

Product Specifications

Background

Gamma-aminobutyric acid type A (GABAA) receptors are members of the neurotransmitter ligand-gated ion channels that mediate neuronal inhibition on binding GABA. The effects of GABA on GABAA receptors are modulated by a range of therapeutically important drugs, including barbiturates, anaesthetics and benzodiazepines.

Synonyms

GABA A receptor beta 3 subunit; GABA alpha receptor beta 2 subunit; GABAA receptor beta 2 subunit; GABAA receptor beta 3 subunit; GABAA receptor subunit beta 2; GABAA receptor subunit beta 3; GABRB2; GABRB3; Gamma Aminobutyric Acid A receptor beta 3; Gamma Aminobutyric Acid receptor beta 2 subunit; Gamma aminobutyric acid receptor subunit beta 2; Gamma aminobutyric acid receptor subunit beta 3; Testis gamma aminobutyric acid receptor subunit beta 3; GBRB2_HUMAN.

Cellular Locus

Cell membrane

Host

Rabbit

Immunogen

301-400/512

Target

GABA A Receptor beta 2 + 3

Clonality

Polyclonal

Isotype

IgG

Conjugation

Unconjugated

Source

KLH conjugated synthetic peptide derived from human GABA A Receptor beta 2 + 3

Applications

WB, ELISA, IHC-P, IHC-F, IF (IHC-P), IF (IHC-F), IF (ICC), IP

Purification

Purified by Protein A.

Concentration

1µg/µl

Dilution

WB (1:300-5000), ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200), IP (1-2ug)